NO174631C - Fremgangsmåte ved fremstilling av homogent rekombinant immuninterferon-fragment, replikerbar vektor samt mikroorganisme - Google Patents

Fremgangsmåte ved fremstilling av homogent rekombinant immuninterferon-fragment, replikerbar vektor samt mikroorganisme

Info

Publication number
NO174631C
NO174631C NO873389A NO873389A NO174631C NO 174631 C NO174631 C NO 174631C NO 873389 A NO873389 A NO 873389A NO 873389 A NO873389 A NO 873389A NO 174631 C NO174631 C NO 174631C
Authority
NO
Norway
Prior art keywords
microorganism
replicable vector
immune interferon
homogeneous recombinant
recombinant immune
Prior art date
Application number
NO873389A
Other languages
English (en)
Norwegian (no)
Other versions
NO873389L (no
NO174631B (no
NO873389D0 (no
Inventor
Heinz Dobeli
Reiner Gentz
Erich Hochuli
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO873389D0 publication Critical patent/NO873389D0/no
Publication of NO873389L publication Critical patent/NO873389L/no
Publication of NO174631B publication Critical patent/NO174631B/no
Publication of NO174631C publication Critical patent/NO174631C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO873389A 1986-08-13 1987-08-12 Fremgangsmåte ved fremstilling av homogent rekombinant immuninterferon-fragment, replikerbar vektor samt mikroorganisme NO174631C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868619725A GB8619725D0 (en) 1986-08-13 1986-08-13 Homogenous interferon fragments

Publications (4)

Publication Number Publication Date
NO873389D0 NO873389D0 (no) 1987-08-12
NO873389L NO873389L (no) 1988-02-15
NO174631B NO174631B (no) 1994-02-28
NO174631C true NO174631C (no) 1994-06-08

Family

ID=10602667

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873389A NO174631C (no) 1986-08-13 1987-08-12 Fremgangsmåte ved fremstilling av homogent rekombinant immuninterferon-fragment, replikerbar vektor samt mikroorganisme

Country Status (21)

Country Link
EP (1) EP0256424B1 (fr)
JP (1) JPS6349098A (fr)
KR (1) KR880002996A (fr)
AR (1) AR244808A1 (fr)
AT (1) ATE67783T1 (fr)
AU (1) AU607930B2 (fr)
DE (1) DE3773295D1 (fr)
DK (1) DK377787A (fr)
ES (1) ES2051714T3 (fr)
FI (1) FI873512A7 (fr)
GB (1) GB8619725D0 (fr)
GR (1) GR3003417T3 (fr)
HU (1) HU202920B (fr)
IE (1) IE60670B1 (fr)
IL (1) IL83474A0 (fr)
MC (1) MC1847A1 (fr)
NO (1) NO174631C (fr)
NZ (1) NZ221374A (fr)
PH (1) PH27432A (fr)
PT (1) PT85538B (fr)
ZA (1) ZA875819B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2969461B2 (ja) * 1988-07-23 1999-11-02 株式会社林原生物化学研究所 ヒトγ−インターフェロンとその製造方法並びに用途
DE3730331A1 (de) * 1987-09-10 1989-03-30 Basf Ag Neue polypeptide, verfahren zur herstellung, die vektoren dafuer und arzneimittel daraus
DE69104619T2 (de) * 1990-08-31 1995-04-13 Schering Corp Verwendungsmethoden von humanem Gammainterferon 4-134.
DE4036856C1 (fr) * 1990-11-19 1992-05-27 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung Ev, 8000 Muenchen, De
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
CN1309423C (zh) 1999-11-12 2007-04-11 马克西根控股公司 干扰素γ偶联物
CA2390292A1 (fr) 1999-11-12 2001-05-25 Maxygen Holdings Ltd. Conjugues d'interferon gamma
US7959910B2 (en) 2000-07-31 2011-06-14 Biolex Therapeutics, Inc. C-terminally truncated interferon alpha variants
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
US7038015B2 (en) 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
CA2491178A1 (fr) 2002-07-03 2004-01-15 Maxygen Holdings Ltd. Variants polypeptidiques a interferon gamma pleine longueur
US20060024272A1 (en) * 2004-07-29 2006-02-02 Large Scale Biology Corporation C-terminally truncated interferon

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0788398B2 (ja) * 1983-10-17 1995-09-27 サントリー株式会社 新規生理活性ポリペプチドおよびその製造法
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
JPS60172999A (ja) * 1983-12-20 1985-09-06 Suntory Ltd 新規な塩基性ポリペプチドおよびその製造法
US4758656A (en) * 1983-12-26 1988-07-19 Kyowa Hakko Kogyo Co., Ltd. Novel human interferon-gamma polypeptide derivative
DE3414831A1 (de) * 1984-04-19 1985-10-31 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit human-gammainterferon-aktivitaet
WO1985005618A1 (fr) * 1984-06-06 1985-12-19 Takeda Chemical Industries, Ltd. Procede de preparation de derives de l'interferon
IL75302A0 (en) * 1984-06-06 1985-09-29 Takeda Chemical Industries Ltd Novel polypeptide and production thereof
JPS6124599A (ja) * 1984-07-11 1986-02-03 Kyowa Hakko Kogyo Co Ltd 新規ヒトインタ−フエロン−ｒポリペプチド誘導体
JPS6163696A (ja) * 1984-09-05 1986-04-01 Asahi Chem Ind Co Ltd 新しいペプチド
JPS61108397A (ja) * 1984-10-31 1986-05-27 Green Cross Corp:The インタ−フエロン−γ蛋白質の製造法
JPS62289600A (ja) * 1986-02-18 1987-12-16 Kanegafuchi Chem Ind Co Ltd インタ−フエロン−γ及びその製造方法

Also Published As

Publication number Publication date
KR880002996A (ko) 1988-05-13
PH27432A (en) 1993-06-21
PT85538B (pt) 1990-06-29
GR3003417T3 (en) 1993-02-17
HU202920B (en) 1991-04-29
IE60670B1 (en) 1994-08-10
HUT47148A (en) 1989-01-30
GB8619725D0 (en) 1986-09-24
FI873512L (fi) 1988-02-14
FI873512A7 (fi) 1988-02-14
NZ221374A (en) 1990-07-26
FI873512A0 (fi) 1987-08-13
AU7668687A (en) 1988-05-19
IE872160L (en) 1988-02-13
EP0256424A1 (fr) 1988-02-24
ES2051714T3 (es) 1994-07-01
IL83474A0 (en) 1988-01-31
PT85538A (en) 1987-09-01
MC1847A1 (fr) 1988-09-30
EP0256424B1 (fr) 1991-09-25
AR244808A1 (es) 1993-11-30
DK377787D0 (da) 1987-07-20
AU607930B2 (en) 1991-03-21
NO873389L (no) 1988-02-15
JPS6349098A (ja) 1988-03-01
NO174631B (no) 1994-02-28
ATE67783T1 (de) 1991-10-15
ZA875819B (en) 1988-02-15
DK377787A (da) 1988-02-14
NO873389D0 (no) 1987-08-12
DE3773295D1 (de) 1991-10-31

Similar Documents

Publication Publication Date Title
IL78472A0 (en) Hepatitis b surface antigen formed by recombinant dna techniques,vaccines,diagnostics,cell lines and methods of forming same
AR241939A1 (es) Metodo para la recombinacion de adn de virus de viruela de ave con adn exogeno.
GB2194538B (en) Processes for the production of hcmv glycoproteins, antibodies thereto and hcmv vaccines, and recombinant vectors therefor
IL67961A0 (en) Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
EP0480356A3 (en) Mos-controlled thyristor and method of making the same
HU9502949D0 (en) Polipeptides, polinucleotides, vectors and host cells, and vaccines against hepatitis virus infection, diagnostics, immunoassay and culturing methods
PH25120A (en) Replicable expression vehicle and process of preparation thereof
NO174631C (no) Fremgangsmåte ved fremstilling av homogent rekombinant immuninterferon-fragment, replikerbar vektor samt mikroorganisme
HUT35288A (en) Homogeneous immune interferon fragment and process for the paration thereof
IL69423A0 (en) Recombinant plasmid inserted with hepatitis b virus gene,yeast transformed with said recombinant plasmid and production of hepatitis b virus surface antigen
EP0105149A3 (en) Recombinant plasmid containing hepatitis b virus gene, yeast transformed with said recombinant plasmid, and production of hepatitis b virus surface antigen
ZA86338B (en) Novel growth hormone-releasing peptides and method of treating mammals therewith
PT84850A (en) Process for isolating and purifying p.falciparum cs protein vaccine expressed in recombinant e.coli
EP0232410A4 (fr) Procede et tampon de lyse pour l'extraction d'un antigene de surface de l'hepatite b a partir de cellules de levure.
PT85461A (en) Process for preparing recombinant htlv-iii proteins and uses thereof
EP0404835A4 (en) Novel recombinant vaccinia virus expression vectors and method of selecting same
DE3666666D1 (en) Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same
PH24409A (en) Expression of hepatitis b viral antigens using recombinant baculovirus vectors
ATA264487A (de) Homogene, rekombinante immun-interferonfragmente
ZA929418B (en) Recombinant vaccines and method of producing same.
EP0244427A4 (fr) Virus recombinant.
IE980257A1 (en) Method of using eukaryotic expression vectors comprising the bk virus enhancer
AU5611486A (en) Hepatitis B surface antigen formed by recombinant DNA techniques, vaccines diagnostics, cell lines and methods of forming same
GB2189591B (en) Heating method and system
IL82749A0 (en) Method of improving optical clarity in reconstituted lyophilized products